Emerging Role of Endoglin (CD105) as a Marker of Angiogenesis with Clinical Potential in Human Malignancies

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|3|6|427-432

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.3, Iss.6, 2003-12, pp. : 427-432

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endoglin (CD105): A Target for Anti-angiogenetic Cancer Therapy

By  

Current Drug Targets, Vol. 4, Iss. 4, 2003-05 ,pp. : 291-296

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Role and Targeting of Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) in Human Malignancies

By  

Clinical Cancer Drugs, Vol. 2, Iss. 2, 2015-10 ,pp. : 100-111

Bentham Science Publishers

Access to resources Recommend Favorite

Pemetrexed and its emerging role in the treatment of thoracic malignancies

By Scagliotti Giorgio V   Novello Silvia  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 5, 2003-05 ,pp. : 853-863

Informa Healthcare

Access to resources Recommend Favorite

Transient Injury-Dependent Up-Regulation of CD105 and its Specific Targeting with an Anti-Vascular Anti-Mouse Endoglin-Nigrin b Immunotoxin

By  

Medicinal Chemistry, Vol. 8, Iss. 6, 2012-11 ,pp. : 996-1002

Bentham Science Publishers

Access to resources Recommend Favorite

The emerging role of clinical audit

By Mason Alastair  

Clinical Medicine, Vol. 2, Iss. 4, 2002-07 ,pp. : 294-296

Royal College Of Physicians

Access to resources Recommend Favorite